INS and obesity disorder: At the same time, in obesity there is a reduced production of adiponectin, the key insulin-sensitizing adipokine, that regulates glucose and lipid metabolism, activates the energy sensor AMPK and protects against inflammation by inhibiting NF-κB activity and obesity-linked insulin resistance [184,185].